The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rinozal 5 mg film-coated tablets

Clonmel Healthcare LtdPA0126/179/001

Main Information

Trade NameRinozal 5 mg film-coated tablets
Active SubstancesLevocetirizine dihydrochloride
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/179/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine


License statusAuthorised
Licence Issued09/10/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0095-001-003
Interchangeable List DocumentPDF of Interchangeable List
« Back